Cerilliant
LACOSAMIDE-13C D3100¡?G/ML IN ACETONITRILE AMPULE OF 1¡ML CERTIFIED REFERENCE MATERIAL CERILLIANT (C005B-225380)
Lacosamide is a new antiepileptic drug approved by the FDA in late 2008 for the treatment of partial-onset seizures and diabetic neuropathic pain. The drug is marketed under the trade name Vimpat ® .
Description
General description
Lacosamide is a new antiepileptic drug approved by the FDA in late 2008 for the treatment of partial-onset seizures and diabetic neuropathic pain. The drug is marketed under the trade name Vimpat®. This internal standard is suitable for lacosamide testing methods by LC/MS or GC/MS for clinical toxicology, forensic analysis, or urine drug testing.
Legal Information
CERILLIANT is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Cerilliant Corporation
Vimpat is a registered trademark of Harris FRC Corporation
Shipping Information:
Hazmat Fee: $65.00 + applicable shipping charges are added after the order is placed.
More Information: https://cenmed.com/shipping-returns
Specifications
- UPC:
- 51282508
- Condition:
- New
- Weight:
- 1.00 Ounces
- HazmatClass:
- Yes
- MPN:
- L-027-1ML
-
Fast shipping — 3-day lead time
-
Guaranteed quality & reliable delivery
-
Shipping Lead-Time: 3-5 Days
